Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 7, 2011, Pages 1099-1101

  Böhm, Michael R R ^a   Uhlig, Constantin E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Bevacizumab; Coats' disease; Cystoid macular edema; Intravitreal; Macula; Triamcinolone

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; ELECTRORETINOGRAPHY; EXUDATIVE RETINITIS; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; NIGHT VISION; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PHOTOPIC VISION; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA EDEMA; SINGLE DRUG DOSE; VISUAL ACUITY; VISUAL FIELD DEFECT;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; ELECTRORETINOGRAPHY; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; OPHTHALMOSCOPY; RETINA; RETINAL TELANGIECTASIS; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 79959686279     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1629-5     Document Type: Article

References (9)

1. Haik BG (1991) Advanced Coats' disease. Trans Am Ophthalmol Soc 89:371-475
2. Shields AS, Shields CL, Honovar SG, Demirci H, Cater J (2001) Classification and management of coats disease: the 2000 Proctor Lecture. Am J Ophthalmol 131:572-583 (Pubitemid 32422113)
3. Andreoli CM, Miller JW (2007) Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 18:502-508 (Pubitemid 351339405)
4. Kim R (2007) Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration. Indian J Ophthalmol 55:413-415
5. Jonas J (2004) Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment. Br J Ophthalmol 88:587-588
6. Jarin RR, Teoh SCB, Lim TH (2006) Resolution of severe macular oedema in adult Coats' syndrome with high-dose intravitreal triamcinolone acetonide. Eye 20:163-165
7. Sun Y, Jain A, Moshfeghi M (2007) Elevated vascular endothelial growth factor levels in Coats' disease: rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 245:1387-1388 (Pubitemid 47278676)
8. Alvarez-Riveria LG, Abraham-Marini ML, Flores-Orta HJ, Mayorquin-Ruiz M, Cortés-Luna CF (2008) Coats' disease treated with bevacizumab (Avastin®). Arch Soc Esp Oftalmol 83:329-332
9. He YG, Wang H, Zhao B, Bahl D, McClustkey J (2010) Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol 248:1519-1521